Fecal microbiota transplantation from patients with polycystic ovary syndrome induces metabolic disorders and ovarian dysfunction in germ-free miceOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study tested whether the gut microbiome helps cause polycystic ovary syndrome (PCOS). Researchers used fecal microbiota transplantation (FMT), moving pooled stool from PCOS patients or healthy women into germ-free mice. Germ-free mice have no resident microbes, so any effect reflects the transplanted community rather than competition or antibiotic side effects. After transplant the team profiled the mouse gut microbiota by 16S rRNA sequencing and measured reproductive hormones, metabolism, estrous cycles, ovaries and gut barrier.
Who was studied?
The donors were 20 women with PCOS (mean age about 28 years) and 20 age-matched healthy controls, recruited at Peking Union Medical College Hospital in China. PCOS was diagnosed by the 2003 Rotterdam criteria. Patients had higher body mass index, body fat, testosterone, fasting insulin, HOMA-IR and triglycerides than controls. The recipients were female germ-free C3H mice, 8 weeks old, split into two groups of 6. Each group received pooled PCOS stool or pooled control stool, then was studied over four weeks.
What were the most important findings?
Mice given PCOS stool developed a distinct microbiota and PCOS-like traits. By Day 28 their gut was enriched in Phocaeicola, Mediterraneibacter, Oscillospiraceae, Lawsonibacter and Rikenellaceae. Compared with control-transplanted mice, PCOS-transplanted mice ate and drank more, gained weight faster and stored more subcutaneous and parauterine fat. They showed insulin resistance by fasting insulin and HOMA-IR, higher testosterone, disrupted estrous cycles, fewer corpora lutea and damaged colonic barrier (reduced occludin). Serum TNF-alpha did not differ. Several genera correlated with testosterone, HOMA-IR and lipids.
What are the greatest implications of this study?
The results suggest the gut microbiome can transmit PCOS features, since a blank germ-free background makes the transplanted community the most likely driver of the metabolic and ovarian changes. This supports the idea that modulating gut bacteria could become a marker or target for long-term PCOS management. Causation should not be overstated. Mice do not fully reproduce human microbiota, donor samples were pooled and only 16S rRNA sequencing was used, so specific species and metabolites still need confirmation.